Cerebrospinal fluid microglia and neurodegenerative markers in twins concordant and discordant for psychotic disorders

European Archives of Psychiatry and Clinical Neuroscience

Volumn 267, Issue 5, 2017, Pages 391-402

  Johansson, Viktoria ^a   Jakobsson, Joel ^b   Fortgang, Rebecca G ^c   Zetterberg, Henrik ^b,d   Blennow, Kaj ^b   Cannon, Tyrone D ^c,e   Hultman, Christina M ^a   Wetterberg, Lennart ^a   Landén, Mikael ^a,b  

^a KAROLINSKA INSTITUTE   (Sweden)

^b UNIVERSITY OF GOTHENBURG   (Sweden)

^c YALE UNIVERSITY   (United States)

^d UNIVERSITY COLLEGE LONDON   (United Kingdom)

^e YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Biomarker; Bipolar disorder; Cerebrospinal fluid; Neuroinflammation; Schizophrenia; Twin study

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID BETA PROTEIN X 38; AMYLOID BETA PROTEIN X 40; AMYLOID BETA PROTEIN X 42; AMYLOID BETA PROTEIN[1-42]; AMYLOID PRECURSOR PROTEIN; AMYLOID PRECURSOR PROTEIN ALPHA; AMYLOID PRECURSOR PROTEIN BETA; C REACTIVE PROTEIN; CHITINASE 3 LIKE PROTEIN 1; CLUSTER OF DIFFERENTIATION 14; HALOPERIDOL; LEVOMEPROMAZINE; MONOCYTE CHEMOTACTIC PROTEIN 1; OLANZAPINE; PEPTIDES AND PROTEINS; PERPHENAZINE; QUETIAPINE; RISPERIDONE; SERUM ALBUMIN; TAU PROTEIN; UNCLASSIFIED DRUG; BIOLOGICAL MARKER; CCL2 PROTEIN, HUMAN; CHI3L1 PROTEIN, HUMAN; LIPOPOLYSACCHARIDE RECEPTOR;

ADULT; ARTICLE; BIPOLAR DISORDER; BLOOD CEREBROSPINAL FLUID BARRIER; BLOOD SAMPLING; BODY MASS; CALIFORNIA VERBAL LEARNING TEST; CEREBROSPINAL FLUID; CEREBROSPINAL FLUID ANALYSIS; CLINICAL ARTICLE; COGNITION; CONTROLLED STUDY; FEMALE; HERITABILITY; HUMAN; LEUKOCYTE COUNT; LUMBAR PUNCTURE; MALE; MICROGLIA; MIDDLE AGED; NEUROPSYCHOLOGICAL TEST; PRIORITY JOURNAL; SCHIZOAFFECTIVE PSYCHOSIS; SCHIZOPHRENIA; SINGLE NUCLEOTIDE POLYMORPHISM; STRUCTURED CLINICAL INTERVIEW FOR DSM DISORDERS; TEMPERAMENT EVALUATION OF MEMPHIS, PISA, PARIS AND SAN DIEGO; TWINS; ZYGOSITY; BLOOD; DIZYGOTIC TWINS; GENETIC PREDISPOSITION; GENETICS; METABOLISM; MONOZYGOTIC TWINS; PSYCHOLOGY; PSYCHOMETRY; PSYCHOSIS; STATISTICS;

ADULT; AMYLOID BETA-PEPTIDES; BIOMARKERS; CHEMOKINE CCL2; CHITINASE-3-LIKE PROTEIN 1; DISEASES IN TWINS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LIPOPOLYSACCHARIDE RECEPTORS; MALE; MIDDLE AGED; PSYCHOMETRICS; PSYCHOTIC DISORDERS; STATISTICS AS TOPIC; TWINS, DIZYGOTIC; TWINS, MONOZYGOTIC;

EID: 85007417010     PISSN: 09401334     EISSN: 14338491     Source Type: Journal    
DOI: 10.1007/s00406-016-0759-5     Document Type: Article

References (65)

1. Merikangas KR et al (2011) Prevalence and correlates of bipolar spectrum disorder in the world mental health survey initiative. Arch Gen Psychiatry 68(3):241–251
2. McGrath J et al (2008) Schizophrenia: a concise overview of incidence, prevalence, and mortality. Epidemiol Rev 30:67–76
3. Lichtenstein P et al (2009) Common genetic determinants of schizophrenia and bipolar disorder in Swedish families: a population-based study. Lancet 373(9659):234–239
4. Cross-Disorder Group of the Psychiatric Genomics Consortium (2013) Identification of risk loci with shared effects on five major psychiatric disorders: a genome-wide analysis. Lancet 381(9875):1371–1379
5. Benros ME et al (2011) Autoimmune diseases and severe infections as risk factors for schizophrenia: a 30-year population-based register study. Am J Psychiatry 168(12):1303–1310
6. Benros ME et al (2013) Autoimmune diseases and severe infections as risk factors for mood disorders: a nationwide study. JAMA Psychiatry 70(8):812–820
7. Johansson V et al (2014) Multiple sclerosis and psychiatric disorders: comorbidity and sibling risk in a nationwide Swedish cohort. Mult Scler 20(14):1881–1891
8. Mors O, Mortensen PB, Ewald H (1999) A population-based register study of the association between schizophrenia and rheumatoid arthritis. Schizophr Res 40(1):67–74
9. Bergink V, Gibney SM, Drexhage HA (2014) Autoimmunity, inflammation, and psychosis: a search for peripheral markers. Biol Psychiatry 75(4):324–331
10. Horvath S, Mirnics K (2014) Immune system disturbances in schizophrenia. Biol Psychiatry 75(4):316–323
11. Upthegrove R, Manzanares-Teson N, Barnes NM (2014) Cytokine function in medication-naive first episode psychosis: a systematic review and meta-analysis. Schizophr Res 155(1–3):101–108
12. Munkholm K et al (2013) Cytokines in bipolar disorder versus healthy control subjects: a systematic review and meta-analysis. J Psychiatr Res 47(9):1119–1133
13. Miller BJ et al (2011) Meta-analysis of cytokine alterations in schizophrenia: clinical status and antipsychotic effects. Biol Psychiatry 70(7):663–671
14. Dargel AA et al (2015) C-reactive protein alterations in bipolar disorder: a meta-analysis. J Clin Psychiatry 76(2):142–150
15. Smith RS (1992) A comprehensive macrophage-T-lymphocyte theory of schizophrenia. Med Hypotheses 39(3):248–257
16. Smith RS (1991) The macrophage theory of depression. Med Hypotheses 35(4):298–306
17. Janova H et al (2016) CD14 is a key organizer of microglial responses to CNS infection and injury. Glia 64(4):635–649
18. Severance EG et al (2013) Discordant patterns of bacterial translocation markers and implications for innate immune imbalances in schizophrenia. Schizophr Res 148(1–3):130–137
19. Jakobsson J et al (2015) Monocyte and microglial activation in patients with mood-stabilized bipolar disorder. J Psychiatry Neurosci 40(4):250–258
20. Padmos RC et al (2008) A discriminating messenger RNA signature for bipolar disorder formed by an aberrant expression of inflammatory genes in monocytes. Arch Gen Psychiatry 65(4):395–407
21. Maier B et al (2005) Physiological levels of pro- and anti-inflammatory mediators in cerebrospinal fluid and plasma: a normative study. J Neurotrauma 22(7):822–835
22. Meier MH et al (2014) Neuropsychological decline in schizophrenia from the premorbid to the postonset period: evidence from a population-representative longitudinal study. Am J Psychiatry 171(1):91–101
23. Xu G et al (2012) Neuropsychological performance in bipolar I, bipolar II and unipolar depression patients: a longitudinal, naturalistic study. J Affect Disord 136(3):328–339
24. Palsson E et al (2013) Neurocognitive function in bipolar disorder: a comparison between bipolar I and II disorder and matched controls. BMC Psychiatry 13:165
25. Blennow K, de Leon MJ, Zetterberg H (2006) Alzheimer’s disease. Lancet 368(9533):387–403
26. Blennow K et al (2015) Amyloid biomarkers in Alzheimer’s disease. Trends Pharmacol Sci 36:297–309
27. Albertini V et al (2012) Distinct cerebrospinal fluid amyloid-beta peptide signatures in cognitive decline associated with Alzheimer’s disease and schizophrenia. Electrophoresis 33(24):3738–3744
28. Dwork AJ et al (1998) Senile degeneration and cognitive impairment in chronic schizophrenia. Am J Psychiatry 155(11):1536–1543
29. Chung JK et al (2016) Beta-amyloid burden is not associated with cognitive impairment in schizophrenia: a systematic review. Am J Geriatr Psychiatry 24(10):923–939
30. Jakobsson J et al (2013) Altered concentrations of amyloid precursor protein metabolites in the cerebrospinal fluid of patients with bipolar disorder. Neuropsychopharmacology 38(4):664–672
31. Piccinni A et al (2012) Plasma beta-amyloid peptides levels: a pilot study in bipolar depressed patients. J Affect Disord 138(1–2):160–164
32. Johansson V et al (2012) Microscopic particles in two fractions of fresh cerebrospinal fluid in twins with schizophrenia or bipolar disorder and in healthy controls. PLoS ONE 7(9):e45994
33. Mobarrez F et al (2013) Microparticles and microscopic structures in three fractions of fresh cerebrospinal fluid in schizophrenia: case report of twins. Schizophr Res 143(1):192–197
34. Spitzer RL et al (1992) The structured clinical interview for DSM-III-R (SCID). I: history, rationale, and description. Arch Gen Psychiatry 49(8):624–629
35. First MB et al (1997) Structured clinical interview for DSM-IV axis II personality disorders (SCID-II). American Psychiatric Press Inc., Washington, DC
36. Raine A (1991) The SPQ: a scale for the assessment of schizotypal personality based on DSM-III-R criteria. Schizophr Bull 17(4):555–564
37. Patton JH, Stanford MS, Barratt ES (1995) Factor structure of the Barratt impulsiveness scale. J Clin Psychol 51(6):768–774
38. Zuckerman M, Link K (1968) Construct validity for the sensation-seeking scale. J Consult Clin Psychol 32(4):420–426
39. Akiskal HS et al (2005) TEMPS-A: validation of a short version of a self-rated instrument designed to measure variations in temperament. J Affect Disord 85(1–2):45–52
40. Andreasen NC (1983) Scale for the assessment of negative symptoms (SANS). University of Iowa, Iowa City
41. Andreasen NC (1984) The scale for the assessment of positive symptoms (SAPS). University of Iowa, Iowa City
42. Hannelius U et al (2007) Large-scale zygosity testing using single nucleotide polymorphisms. Twin Res Hum Genet 10(4):604–625
43. Akaike H (1987) Factor analysis and AIC. Psychometrika 52(3):317–332
44. Kline RB (2011) Principles and practice of structural equation modeling, 3rd edn. The Guilford Press, New York
45. Neale M et al (2003) Mx: Statistical modeling. Department of Psychiatry, Virginia Institute for Psychiatric and Behavior Genetics, Virginia Commonwealth University, Richmond
46. Jakobsson J et al (2015) Monocyte and microglial activation in patients with mood-stabilized bipolar disorder. J Psychiatry Neurosci 40(2):140183
47. Brodin P et al (2015) Variation in the human immune system is largely driven by non-heritable influences. Cell 160(1–2):37–47
48. LeVan TD et al (2001) A common single nucleotide polymorphism in the CD14 promoter decreases the affinity of Sp protein binding and enhances transcriptional activity. J Immunol 167(10):5838–5844
49. Baldini M et al (1999) A polymorphism* in the 5′ flanking region of the CD14 gene is associated with circulating soluble CD14 levels and with total serum immunoglobulin E. Am J Respir Cell Mol Biol 20(5):976–983
50. de la Fontaine L et al (2006) Investigating disease susceptibility and the negative correlation of schizophrenia and rheumatoid arthritis focusing on MIF and CD14 gene polymorphisms. Psychiatry Res 144(1):39–47
51. Haziot A et al (1988) The monocyte differentiation antigen, CD14, is anchored to the cell membrane by a phosphatidylinositol linkage. J Immunol 141(2):547–552
52. Bazil V et al (1989) Structural relationship between the soluble and membrane-bound forms of human monocyte surface glycoprotein CD14. Mol Immunol 26(7):657–662
53. Olsson B et al (2013) Microglial markers are elevated in the prodromal phase of Alzheimer’s disease and vascular dementia. J Alzheimers Dis 33(1):45–53
54. Yin GN et al (2009) Role of soluble CD14 in cerebrospinal fluid as a regulator of glial functions. J Neurosci Res 87(11):2578–2590
55. Bernstein HG et al (2016) Morphometric analysis of the cerebral expression of ATP-binding cassette transporter protein ABCB1 in chronic schizophrenia: Circumscribed deficits in the habenula. Schizophr Res. doi:10.1016/j.schres.2016.02.036
56. Zetterberg H et al (2014) Blood-cerebrospinal fluid barrier dysfunction in patients with bipolar disorder in relation to antipsychotic treatment. Psychiatry Res 217(3):143–146
57. Bechter K et al (2010) Cerebrospinal fluid analysis in affective and schizophrenic spectrum disorders: identification of subgroups with immune responses and blood–CSF barrier dysfunction. J Psychiatr Res 44(5):321–330
58. Muller N, Ackenheil M (1995) Immunoglobulin and albumin content of cerebrospinal fluid in schizophrenic patients: relationship to negative symptomatology. Schizophr Res 14(3):223–228
59. Prince JA et al (2004) APOE epsilon4 allele is associated with reduced cerebrospinal fluid levels of Abeta42. Neurology 62(11):2116–2118
60. Lautner R et al (2014) Apolipoprotein E genotype and the diagnostic accuracy of cerebrospinal fluid biomarkers for Alzheimer disease. JAMA Psychiatry 71(10):1183–1191
61. Gatt JM et al (2015) Specific and common genes implicated across major mental disorders: a review of meta-analysis studies. J Psychiatr Res 60:1–13
62. Gonzalez-Castro TB et al (2015) No association between ApoE and schizophrenia: evidence of systematic review and updated meta-analysis. Schizophr Res 169(1–3):355–368
63. Sutin AR et al (2012) Impulsivity-related traits are associated with higher white blood cell counts. J Behav Med 35(6):616–623
64. Sutin AR et al (2010) High neuroticism and low conscientiousness are associated with interleukin-6. Psychol Med 40(9):1485–1493
65. Fortgang RG et al (2016) Multidimensional assessment of impulsivity in schizophrenia, bipolar disorder, and major depressive disorder: testing for shared endophenotypes. Psychol Med 46(7):1497–1507